Cargando…

Identification of a novel 5-methylcytosine-related signature for prognostic prediction of kidney renal papillary cell carcinoma and a Putative target for drug repurposing

BACKGROUND: Many studies have demonstrated the crucial roles of 5-methylcytosine (m5C) RNA methylation in cancer pathogenesis. METHODS: Two datasets, including TCGA-KIRP and ICGC, and related clinical information were downloaded, where the expression of 13 m5C regulators was examined. We applied LAS...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhen, Cao, Chunhua, Zhou, Chun-Li, Li, Xilong, Miao, Changhong, Shen, Li, Singla, Rajeev K., Lu, Xihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400932/
https://www.ncbi.nlm.nih.gov/pubmed/37523897
http://dx.doi.org/10.1016/j.tranon.2023.101741
_version_ 1785084550284574720
author Zhang, Zhen
Cao, Chunhua
Zhou, Chun-Li
Li, Xilong
Miao, Changhong
Shen, Li
Singla, Rajeev K.
Lu, Xihua
author_facet Zhang, Zhen
Cao, Chunhua
Zhou, Chun-Li
Li, Xilong
Miao, Changhong
Shen, Li
Singla, Rajeev K.
Lu, Xihua
author_sort Zhang, Zhen
collection PubMed
description BACKGROUND: Many studies have demonstrated the crucial roles of 5-methylcytosine (m5C) RNA methylation in cancer pathogenesis. METHODS: Two datasets, including TCGA-KIRP and ICGC, and related clinical information were downloaded, where the expression of 13 m5C regulators was examined. We applied LASSO regression to construct a multi-m5C-regulator-based signature in the TCGA cohort, which was further validated using the ICGC cohort. Univariate and multivariate Cox regressions were applied to evaluate the independent prognostic value of our model. The differences in biological functions and immune characterizations between high and low-risk groups divided based on the risk scores were also investigated via multiple approaches, such as enrichment analyses, mutation mining, and immune scoring. Finally, the sensitivities of commonly used targeted drugs were tested, and the connectivity MAP (cMAP) was utilized to screen potentially effective molecules for patients in the high-risk group. Experimental validation was done following qPCR tests in Caki-2 and HK-2 cell lines. RESULTS: 3 m5C regulators, including ALYREF, DNMT3B and YBX1, were involved in our model. Survival analysis revealed a worse prognosis for patients in the high-risk group. Cox regression results indicated our model's superior predictive performance compared to single-factor prognostic evaluation. Functional enrichment analyses indicated a higher mutation frequency and poorer tumor microenvironment of patients in the high-risk group. qPCR-based results revealed that ALYREF, DNMT3B, and YBX1 were significantly up-regulated in Caki-2 cell lines compared with HK-2 cell lines. Molecules like BRD-K72451865, Levosimendan, and BRD-K03515135 were advised by cMAP for patients in the high-risk group. CONCLUSION: Our study presented a novel predictive model for KIRP prognosis. Furthermore, the results of our analysis provide new insights for investigating m5C events in KIRP pathogenesis.
format Online
Article
Text
id pubmed-10400932
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Neoplasia Press
record_format MEDLINE/PubMed
spelling pubmed-104009322023-08-05 Identification of a novel 5-methylcytosine-related signature for prognostic prediction of kidney renal papillary cell carcinoma and a Putative target for drug repurposing Zhang, Zhen Cao, Chunhua Zhou, Chun-Li Li, Xilong Miao, Changhong Shen, Li Singla, Rajeev K. Lu, Xihua Transl Oncol Commentary BACKGROUND: Many studies have demonstrated the crucial roles of 5-methylcytosine (m5C) RNA methylation in cancer pathogenesis. METHODS: Two datasets, including TCGA-KIRP and ICGC, and related clinical information were downloaded, where the expression of 13 m5C regulators was examined. We applied LASSO regression to construct a multi-m5C-regulator-based signature in the TCGA cohort, which was further validated using the ICGC cohort. Univariate and multivariate Cox regressions were applied to evaluate the independent prognostic value of our model. The differences in biological functions and immune characterizations between high and low-risk groups divided based on the risk scores were also investigated via multiple approaches, such as enrichment analyses, mutation mining, and immune scoring. Finally, the sensitivities of commonly used targeted drugs were tested, and the connectivity MAP (cMAP) was utilized to screen potentially effective molecules for patients in the high-risk group. Experimental validation was done following qPCR tests in Caki-2 and HK-2 cell lines. RESULTS: 3 m5C regulators, including ALYREF, DNMT3B and YBX1, were involved in our model. Survival analysis revealed a worse prognosis for patients in the high-risk group. Cox regression results indicated our model's superior predictive performance compared to single-factor prognostic evaluation. Functional enrichment analyses indicated a higher mutation frequency and poorer tumor microenvironment of patients in the high-risk group. qPCR-based results revealed that ALYREF, DNMT3B, and YBX1 were significantly up-regulated in Caki-2 cell lines compared with HK-2 cell lines. Molecules like BRD-K72451865, Levosimendan, and BRD-K03515135 were advised by cMAP for patients in the high-risk group. CONCLUSION: Our study presented a novel predictive model for KIRP prognosis. Furthermore, the results of our analysis provide new insights for investigating m5C events in KIRP pathogenesis. Neoplasia Press 2023-07-29 /pmc/articles/PMC10400932/ /pubmed/37523897 http://dx.doi.org/10.1016/j.tranon.2023.101741 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Commentary
Zhang, Zhen
Cao, Chunhua
Zhou, Chun-Li
Li, Xilong
Miao, Changhong
Shen, Li
Singla, Rajeev K.
Lu, Xihua
Identification of a novel 5-methylcytosine-related signature for prognostic prediction of kidney renal papillary cell carcinoma and a Putative target for drug repurposing
title Identification of a novel 5-methylcytosine-related signature for prognostic prediction of kidney renal papillary cell carcinoma and a Putative target for drug repurposing
title_full Identification of a novel 5-methylcytosine-related signature for prognostic prediction of kidney renal papillary cell carcinoma and a Putative target for drug repurposing
title_fullStr Identification of a novel 5-methylcytosine-related signature for prognostic prediction of kidney renal papillary cell carcinoma and a Putative target for drug repurposing
title_full_unstemmed Identification of a novel 5-methylcytosine-related signature for prognostic prediction of kidney renal papillary cell carcinoma and a Putative target for drug repurposing
title_short Identification of a novel 5-methylcytosine-related signature for prognostic prediction of kidney renal papillary cell carcinoma and a Putative target for drug repurposing
title_sort identification of a novel 5-methylcytosine-related signature for prognostic prediction of kidney renal papillary cell carcinoma and a putative target for drug repurposing
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400932/
https://www.ncbi.nlm.nih.gov/pubmed/37523897
http://dx.doi.org/10.1016/j.tranon.2023.101741
work_keys_str_mv AT zhangzhen identificationofanovel5methylcytosinerelatedsignatureforprognosticpredictionofkidneyrenalpapillarycellcarcinomaandaputativetargetfordrugrepurposing
AT caochunhua identificationofanovel5methylcytosinerelatedsignatureforprognosticpredictionofkidneyrenalpapillarycellcarcinomaandaputativetargetfordrugrepurposing
AT zhouchunli identificationofanovel5methylcytosinerelatedsignatureforprognosticpredictionofkidneyrenalpapillarycellcarcinomaandaputativetargetfordrugrepurposing
AT lixilong identificationofanovel5methylcytosinerelatedsignatureforprognosticpredictionofkidneyrenalpapillarycellcarcinomaandaputativetargetfordrugrepurposing
AT miaochanghong identificationofanovel5methylcytosinerelatedsignatureforprognosticpredictionofkidneyrenalpapillarycellcarcinomaandaputativetargetfordrugrepurposing
AT shenli identificationofanovel5methylcytosinerelatedsignatureforprognosticpredictionofkidneyrenalpapillarycellcarcinomaandaputativetargetfordrugrepurposing
AT singlarajeevk identificationofanovel5methylcytosinerelatedsignatureforprognosticpredictionofkidneyrenalpapillarycellcarcinomaandaputativetargetfordrugrepurposing
AT luxihua identificationofanovel5methylcytosinerelatedsignatureforprognosticpredictionofkidneyrenalpapillarycellcarcinomaandaputativetargetfordrugrepurposing